Large study adds to growing body of evidence that vaping may harm the heart
April 03, 2024
FDA Clears First AI to Aid Heart Failure Detection During Routine Check-ups
April 3, 2024 — - Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung…
Read More
In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization, the American College of Cardiology (ACC) has planned a full range of educational programming, special events and peer networking scheduled throughout the April 6-8 event in Atlanta, GA. 
Christine Book
April 03, 2024
American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24
April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the…
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death
April 03, 2024
FDA Announces Teleflex and Arrow International Recall of ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits for Increased Resistance That May Lead to Vessel Injuries, Narrowing, or Blockage
April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are…
Read More
Study shows women quickly catch up to men in terms of cardiovascular risk
April 02, 2024
Heart Health Declines Rapidly After Menopause
April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to…
Read More
Study finds patients on average consume more than twice the recommended daily amount of sodium with little variation across socioeconomic groups
April 02, 2024
Majority of People with Heart Disease Consume Too Much Sodium
April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume…
Read More
Concept Medical has received FDA IDE Approval for a US Clinical Study of its MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter..
April 02, 2024
Concept Medical Receives FDA IDE Approval for US Clinical Study of MagicTouch AVF Indication
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational…
Read More
Large study adds to growing body of evidence that vaping may harm the heart
April 02, 2024
Study Links E-Cigarette Use with Higher Risk of Heart Failure
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those…
Read More
Abbott has announced U.S Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve.
April 02, 2024
Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its-…
Read More
Approvals based on positive CLEAR Outcomes data and reflect a highly differentiated product profile
April 01, 2024
U.S. FDA Approves Broad New Labels for NEXLETOL and NEXLIZET to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new…
Read More
Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number
April 01, 2024
New Technology Promises to Revolutionize Valvular Heart Disease Care
April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health…
Read More
Analysis signals higher risk of hypertension among females resting less than seven hours compared with males, according to data to be presented at the upcoming American College of Cardiology Annual Scientific Session & Expo, ACC.24, to be held April 6-8 in Atlanta, GA.
April 01, 2024
Getting Too Little Sleep Linked to High Blood Pressure
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over…
Read More
While likelihood of cardiomyopathy grows over time, the overall risk remains low
March 29, 2024
ADHD Stimulants May Increase Risk of Heart Damage in Young Adults
March 29, 2024 — Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder (…
Read More
V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at ACC24
March 29, 2024
V-Wave to Present Late-Breaking Data from Pivotal RELIEVE-HF Study at American College of Cardiology Annual Scientific Session and Expo
March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American…
Read More
The Evolut FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
March 28, 2024
Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and…
Read More
Findings from the admIRE study – freedom from atrial arrhythmia recurrence at 12 months – support the submission of the VARIPULSE Platform among U.S. patients
March 28, 2024
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation
March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
CREDENCE and PACIFIC-1 study data demonstrate potential power of AI-QCT ISCHEMIA
March 28, 2024
Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials
March 28, 2024 —  Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart…
Read More
March 27, 2024
FDA Approves Johnson & Johnson OPSYNVI (macitentan and tadalafil) Single-Tablet Combination for Patients with Pulmonary Arterial Hypertension (PAH)
March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved…
Read More
Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its DynamX BTK System, a novel, adaptive implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia (CLTI). The company reports this broadens the use of the novel bioadaptor platform technology beyond the treatment of coronary artery disease.
March 27, 2024
Elixir Medical Receives FDA Breakthrough Device Designation for DynamX BTK System for Below-The-Knee Arterial Disease
March 27, 2024 — Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and…
Read More
The largest prospective registry of its kind will build upon clinical data supporting the use of plaque insights to empower clinical decision making for patients with suspected coronary artery disease
March 27, 2024
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
March 27 2024 — HeartFlow, Inc., a leader in AI-driven healthcare technology, announced the launch of the DECIDE…
Read More
WINREVAIR on top of background therapy significantly improved exercise capacity and multiple important secondary outcome measures compared to background therapy alone
March 27, 2024
FDA Approves Merck’s WINREVAIR, a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension
March 27, 2024 — Merck, known as MSD outside of the United States and Canada, announced  that the U.S. Food and Drug…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now